glp-1 news oct 9 2025 GLP-1R Race in 2025: 8 Essential Takeaways Drug Developers Need to Know Bending the Cost Curve: Understanding

Exogenous MOTS-c is now in early-phase human trials

Timing patterns across both routes

Certain individuals should avoid or use caution with CJC 1295, especially those with: Hormone-sensitive cancer s (GH can promote cell growth, which may be risky for those with a history of cancer) Diabetes or insulin resistance (GH impacts blood sugar levels) Severe cardiovascular conditions (fluid retention can increase blood pressure) For anyone considering CJC 1295, its always best to consult a healthcare provider to weigh the benefits against potential risks

They can be taken together without negative interactions, though starting with one at a time allows you to assess individual responses

Editor information Editors and Affiliations Rights and permissions Copyright information 2026 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd